ReviewPharmaceuticals (Basel, Switzerland)2025

Potential Implications of Body Mass Composition Changes in Heart Failure Patients in the Era of SGLT2i, GLP-1 RA, and GIP/GLP-1 RA.

Katarzyna Gryglewska-Wawrzak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.